Venn Life Sciences Share News (VENN)

Venn Life Sciences signs EUR1m contract

(ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company. The AIM listed clinical research organisation announced the deal on Friday. The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and

Venn Life Sciences Wins Leukaemia Project Worth Over EUR1 Million

Venn Life Sciences Appoints Kinesis Pharma's Groen Executive Director

Venn Life posts narrow interim loss, acquires Kinesis

(ShareCast News) - Clinical trial services provider Venn Life Sciences posted a narrower interim pre-tax loss and has agreed to acquire Kinesis Pharma BV. In the six months to the end of June, the London-listed company saw its pre-tax loss narrow from €987,000 (£716,000) to €259,000, while revenue a

Venn Life Sciences To Buy Kinesis Pharma As Interim Loss Narrows (ALLISS)

Venn Life Sciences reports strong first-half trading

(ShareCast News) - Venn Life sciences said it has had a strong first half, with revenues up 170% on the previous year. In a very brief trading update, the company, which provides clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, reported

Venn Life Sciences Says Strong First Half Driven By Contract Wins

Venn Life Sciences Sees "Further Solid Trading" In First Half

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead

AGM, EGM Calendar - Week Ahead